Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Alpha-1 Antitrypsin in Cystic Fibrosis
NCT00499837Phase 2Completed
- Sponsor
- Kamada Ltd.
- Start
- Sep 2007
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha1-proteinase inhibitor (human) in cystic fibrosis (CF), sponsored by Kamada Ltd.. Started Sep 2007; status: completed.
02
Drugs
alpha1-proteinase inhibitor (human)
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00499837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499837.